人妻中出视频

Skip to main content

Potential HIV Drug Keeps Virus Out of Cells

SALT LAKE CITY鈥擣ollowing up a pioneering 2007 proof-of-concept study, a 人妻中出视频 of Utah biochemist and colleagues have developed a promising new anti-HIV drug candidate, PIE12-trimer, that prevents HIV from attacking human cells.
 
Michael S. Kay, M.D., Ph.D., associate professor of biochemistry in the U School of Medicine and senior author of the study published Wednesday, Aug. 18, 2010, online by the Journal of Virology, is raising funds to begin animal safety studies, followed by human clinical trials in two to three years. Kay believes PIE12-trimer is ideally suited for use as a vaginal microbicide (topically applied drug) to prevent HIV infection. His research group is particularly focused on preventing the spread of HIV in Africa, which has an estimated two-thirds of the world鈥檚 33 million HIV patients according to the World 人妻中出视频 Organization.
 
鈥淲e believe that PIE12-trimer could provide a major new weapon in the arsenal against HIV/AIDS. Because of its ability to block the virus from infecting new cells, PIE12-trimer has the potential to work as a microbicide to prevent people from contracting HIV and as a treatment for HIV infected people. HIV can develop resistance rapidly to existing drugs, so there is a constant need to develop new drugs in hopes of staying ahead of the virus.鈥 Kay said. PIE12-trimer was designed with a unique 鈥渞esistance capacitor鈥 that provides it with a strong defense against the emergence of drug-resistant viruses. 

Peptide drugs have great therapeutic potential, but are often hampered by their rapid degradation in the body. D-peptides are mirror-image versions of natural peptides that cannot be broken down, potentially leading to higher potency and longevity in the body.  Despite these potential advantages, no D-peptides have yet been developed.
 
PIE12-trimer consists of three D-peptides (PIE12) linked together that block a 鈥減ocket鈥 on the surface of HIV critical for HIV鈥檚 gaining entry into the cell.  鈥淐linical trials will determine if PIE12-trimer is as effective in humans as it is in the lab,鈥 Kay said.
Across the world, HIV occurs in many different strains and has the ability to mutate to resist drugs aimed at stopping it. Due to the high conservation of the pocket region across strains, PIE12-trimer worked against all major HIV strains worldwide, from Southeast Asia and South America to the United States and Africa.
 
To help advance toward human clinical trials, Kay and co-authors Brett D. Welch, Ph.D., and Debra M. Eckert, Ph.D., research assistant professor of biochemistry, formed a company, Kayak Biosciences, which is owned by the 人妻中出视频 of Utah Research Foundation. If PIE12-trimer proves to be an effective and safe drug against HIV, the same D-Peptide drug design principles can be applied against other viruses, according to Kay. Approval of the first D-peptide drug would also greatly stimulate development of other D-peptide drugs.
 
The study鈥檚 first authors are Welch, and U of U graduate student J. Nicholas Francis. Also contributing were U graduate students Joseph Redman and Matthew Weinstock, as well as Eckert. Images of how PIE12 binds to the HIV pocket were obtained using X-ray crystallography, a technology that provides high-resolution analysis of atomic structures, and were provided by Frank Whitby, Ph.D., research assistant professor of biochemistry, and Christopher P. Hill, Ph.D., professor and co-chair of the Department of Biochemistry. The study includes colleagues from Thomas Jefferson 人妻中出视频 in Philadelphia and Monogram Biosciences, South San Francisco, Calif.

This research was funded by the National Institutes of 人妻中出视频 and the 人妻中出视频 of Utah Research Foundation.